Lianhe Li1,2, Ru Wang1, Shizhi He1, Xixi Shen1, Fanyong Kong3, Shuchun Li4, Huanhu Zhao4, Meng Lian5, Jugao Fang6. 1. Beijing Tongren Hospital, Capital Medical University, Beijing, China. 2. Central Hospital of Chaoyang, Liaoning, China. 3. The Hospital of Shunyi District Beijing, Beijing, China. 4. School of Pharmaceutical Sciences, Minzu University of China, Beijing, China. 5. Beijing Tongren Hospital, Capital Medical University, Beijing, China. lianmeng19861222@163.com. 6. Beijing Tongren Hospital, Capital Medical University, Beijing, China. fangjugao@163.com.
Abstract
PURPOSE: To identify potential molecular markers for induction chemotherapy of Laryngeal squamous cell carcinoma (LSCC). METHODS: Differently expressed genes between chemo-sensitive group (seven cases) and chemo-insensitive (five cases) group after induction chemotherapy by TPF were identified by microarrays. Bayes network and Random forest analyses were employed to identify core genes for induction chemotherapy. The diagnostic value of these core genes was also evaluated by ROC analysis. RESULTS: Six genes (SPP1, FOLR3, KYNU, LOC653219, ADH7 and XAGE1A) are highly expressed, while seven gene (CADM1, NDUFA4L2, CCND2, RARRES3, ERAP2, LYD6 and CNTNAP2) present significantly low expression. Among these genes, genes CADM1, FOLR3, KYNU, and CNTNAP2 are core candidates for LSCC chemo-sensitivity. And that the low expression of CADM1 may result in chemo-sensitivity, which leads to high expression of gene FOLR3 and KYNU, and low expression of gene CNTNAP2. Besides, ROC analysis shows that these four genes exhibit effective diagnostic value for induction chemo-sensitivity. CONCLUSIONS: CADM1 may be a potential molecular marker for LSCC induction chemotherapy, while CADM1, FOLR3, KYNU, and CNTNAP2 may provide essential guidance for LSCC diagnosis and follow-up treatment strategies.
PURPOSE: To identify potential molecular markers for induction chemotherapy of Laryngeal squamous cell carcinoma (LSCC). METHODS: Differently expressed genes between chemo-sensitive group (seven cases) and chemo-insensitive (five cases) group after induction chemotherapy by TPF were identified by microarrays. Bayes network and Random forest analyses were employed to identify core genes for induction chemotherapy. The diagnostic value of these core genes was also evaluated by ROC analysis. RESULTS: Six genes (SPP1, FOLR3, KYNU, LOC653219, ADH7 and XAGE1A) are highly expressed, while seven gene (CADM1, NDUFA4L2, CCND2, RARRES3, ERAP2, LYD6 and CNTNAP2) present significantly low expression. Among these genes, genes CADM1, FOLR3, KYNU, and CNTNAP2 are core candidates for LSCC chemo-sensitivity. And that the low expression of CADM1 may result in chemo-sensitivity, which leads to high expression of gene FOLR3 and KYNU, and low expression of gene CNTNAP2. Besides, ROC analysis shows that these four genes exhibit effective diagnostic value for induction chemo-sensitivity. CONCLUSIONS:CADM1 may be a potential molecular marker for LSCC induction chemotherapy, while CADM1, FOLR3, KYNU, and CNTNAP2 may provide essential guidance for LSCC diagnosis and follow-up treatment strategies.
Authors: June Corry; Danny Rischin; Sue Cotton; Ieta D'Costa; Margaret Chua; Neil Vallance; Bernard Lyons; Stephen Kleid; Andrew Sizeland; Lester J Peters Journal: J Med Imaging Radiat Oncol Date: 2011-04 Impact factor: 1.735
Authors: Yuan Yuan; Dag André Nymoen; Hiep Phuc Dong; Ola Bjørang; Ie-Ming Shih; Philip S Low; Claes G Trope'; Ben Davidson Journal: Hum Pathol Date: 2009-05-19 Impact factor: 3.466
Authors: S McAvoy; S C Ganapathiraju; A L Ducharme-Smith; J R Pritchett; F Kosari; D S Perez; Y Zhu; C D James; D I Smith Journal: Cytogenet Genome Res Date: 2007 Impact factor: 1.636
Authors: Yafei Liu; Guanchao Ye; Bo Dong; Lan Huang; Chunyang Zhang; Yinliang Sheng; Bin Wu; Lu Han; Chunli Wu; Yu Qi Journal: Ann Transl Med Date: 2022-03